1171016-90-2

Upstream product

• 82657-71-4 (4-isopropoxyphenyl)methanol 
• 623-05-2 (4-hydroxyphenyl)methanol 
• 1401335-14-5 methyl 2-[(4-isopropoxyphenyl)methyl]-3-oxobutanoate 
• 329044-14-6 1,2-dihydro-4-[(4-isopropoxyphenyl)methyl]-5-methyl-3H-pyrazol-3-one 
• 124-63-0 methanesulfonyl chloride 

Downstream Products

• 329045-45-6 [14C]-Remogliflozin 
• 1338796-70-5 5-methyl-1-(propan-2-yl)-4- [4-(propan-2-yloxy)benzyl]-1H-pyrazol-3-yl 2,3,4,6-tetra-O-acetyl-β-D-glucopyranoside 
• 1028026-83-6 5-methyl-1-(propan-2-yl)-4-[4-(propan-2-yloxy)benzyl]-1,2-dihydro-3H-pyrazol-3-one 

Relevant academic research and scientific papers

AN IMPROVED PROCESS FOR THE PREPARATION REMOGLIFLOZIN ETABONATE OR PHARMACEUTICALLY ACCEPTABLE SALT, SOLVATE, HYDRATE THEREOF

The present invention relates to an improved process for the preparation of Remogliflozin, Remogliflozin etabonate or pharmaceutically acceptable salt, solvate, hydrate thereof. The present invention relates to an improved process for preparation of Remog

CHEMICAL PROCESS

Disclosed herein are processes for preparing glucopyranosyloxypyrazole derivatives and pyrazole intermediates of the same. In particular, the present invention relates to glucopyranosyloxypyrazole derivatives having SGLT2 inhibitory activity and processes